Skip to main content
OpenTrials

Clinical trial condition

Urticaria

Explore clinical trials studying Urticaria. Study availability and eligibility vary by location and protocol.

326 public trials 46 recruiting studies
Refine in advanced search Browse all conditions

Urticaria trial results

Recruiting

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

NCT06868212

Conditions
Chronic Disease, Chronic Spontaneous Urticaria (CSU), Chronic Urticaria, +10 more
Locations
  • Allervie Clinical Research Birmingham, Alabama, United States
  • Cahaba Derm and skin hlth ctr 27 Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Peak Dermatology Payson, Arizona, United States
View all 132 locations
View Trial Details
Recruiting

Study of Oral Deucrictibant XR Tablet for Prophylaxis and Deucrictibant Soft Capsule for On-Demand Treatment of Angioedema Attacks in Adults With Acquired Angioedema Due to C1 Inhibitor Deficiency

NCT07266805

Conditions
Acquired Angioedema Due to C1-Inhibitor Deficiency (AAE-C1-INH), Acquired angioedema, Angioedema, +15 more
Locations
  • Study Site San Diego, California, United States
  • Study Site Walnut Creek, California, United States
  • Study Site St Louis, Missouri, United States
  • Study Site Hershey, Pennsylvania, United States
View all 32 locations
View Trial Details
Recruiting

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

NCT06865651

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +15 more
Locations
  • Ziaderm Research LLC North Miami Beach, Florida, United States
  • Endeavor Health Glenview, Illinois, United States
  • Novartis Investigative Site Grenoble, France
  • Novartis Investigative Site Montpellier, France
View all 17 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of Tacabrutideg (BGB-16673) in Adults With Chronic Spontaneous Urticaria and in Healthy Participants

NCT07005713

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
  • Dermatology Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Union Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View Trial Details
Recruiting

Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)

NCT07428499

Conditions
Angioedema, Angioedemas, Hereditary, Cardiovascular Diseases, +17 more
Locations
  • ADARx Clinical Site Litchfield Park, Arizona, United States
  • ADARx Clinical Site Little Rock, Arkansas, United States
  • ADARx Clinical Site San Diego, California, United States
  • ADARx Clinical Site Walnut Creek, California, United States
View all 48 locations
View Trial Details

Related conditions